Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 67 pages
Exam (elaborations)

Stanford University INDE 247B Foundations of Medicine V B – Microbiology Capstone, Pharmacology Capstone, MIC/CMS Study Guide, Original Practice Questions & Answers, Stanford Medical School Exam Preparation, Comprehensive Medicine Review, Microbiology, Ph

Document preview thumbnail
Preview 4 out of 67 pages

Prepare for Stanford University School of Medicine INDE 247B – Foundations of Medicine V B: Microbiology Capstone, Pharmacology Capstone, MIC/CMS with an independently created medical-school study resource featuring original practice questions and answers for structured course review and assessment preparation. The course title identifies three integrated components—Microbiology Capstone, Pharmacology Capstone, and MIC/CMS—within Stanford's Foundations of Medicine curriculum, making microbiology, pharmacology, antimicrobial therapy, infectious disease mechanisms, medication effects, clinical application, and comprehensive medical knowledge key areas for targeted review. This resource is suitable for students searching for Stanford INDE 247B study guide, INDE 247B practice questions, Foundations of Medicine V B, Microbiology Capstone, Pharmacology Capstone, MIC/CMS review, Stanford medical school study materials, microbiology exam preparation, and pharmacology exam preparation. These are independently created study materials and are not official Stanford examination questions, faculty materials, answer keys, or protected assessment content.

Content preview

INDE 247B Foundations of Medicine V B –
Microbiology Capstone, Pharmacology
Capstone, MIC/CMS Study Guide, Original
Practice Questions & Answers, Stanford
Medical School Exam Preparation,
Comprehensive Medicine Review,
Microbiology, Pharmacology, Antimicrobial
Therapy, Infectious Diseases, Clinical
Microbiology, Drug Mechanisms, Adverse
Effects, Drug Interactions, Diagnostic Testing,
Patient Management & Clinical Decision-
Making
Question 1: In the context of microbial pathogenesis, which of the following
best describes the role of bacterial biofilms in chronic infections?
A. They promote rapid bacterial replication leading to acute septic shock.
B. They facilitate immune evasion and increase resistance to antimicrobial agents
through a matrix-enclosed community.
C. They act as a direct toxin that destroys host epithelial cells.
D. They enhance the efficacy of bacteriostatic antibiotics by concentrating them at the
infection site.
CORRECT ANSWER: B. They facilitate immune evasion and increase resistance
to antimicrobial agents through a matrix-enclosed community.
Rationale: Biofilms are structured communities of bacterial cells enclosed in a self-
produced polymeric matrix that adheres to surfaces. This matrix acts as a physical
barrier, impeding phagocytosis and the penetration of antibiotics, contributing
significantly to the persistence of chronic infections.
Question 2: A 45-year-old patient with a history of chronic obstructive
pulmonary disease (COPD) presents with a productive cough and fever.
Sputum culture reveals gram-negative, oxidase-positive, non-fermenting bacilli
with a distinct fruity odor. Which antimicrobial class is most appropriate for
targeted therapy against this pathogen?
A. Penicillins
B. Cephalosporins
C. Aminoglycosides
D. Macrolides
CORRECT ANSWER: C. Aminoglycosides

,Rationale: The description (gram-negative, oxidase-positive, non-fermenting, fruity
odor) is characteristic of Pseudomonas aeruginosa. While combination therapy is often
used, aminoglycosides (like tobramycin or gentamicin) are a cornerstone of targeted
anti-pseudomonal therapy, especially in respiratory infections, due to their potent
activity against this pathogen.
Question 3: A patient on linezolid therapy for a vancomycin-resistant
Enterococcus (VRE) infection develops severe thrombocytopenia. The
mechanism of this adverse drug reaction is most directly related to which of
the following pharmacological properties of linezolid?
A. Inhibition of mitochondrial protein synthesis
B. Irreversible inhibition of monoamine oxidase (MAO)
C. Blockade of voltage-gated sodium channels
D. Antagonism of vitamin K-dependent clotting factors
CORRECT ANSWER: A. Inhibition of mitochondrial protein synthesis
Rationale: Linezolid binds to the 23S rRNA of the 50S ribosomal subunit, inhibiting
bacterial protein synthesis. However, it also inhibits mitochondrial protein synthesis in
mammalian cells due to similarities between bacterial and mitochondrial ribosomes.
This leads to myelosuppression, particularly thrombocytopenia, with prolonged use.
Question 4: The capsular polysaccharide of Streptococcus pneumoniae is a
critical virulence factor. Its primary mechanism for evading the host immune
system is:
A. Direct inactivation of complement protein C3a
B. Mimicry of host MHC class I molecules
C. Impairment of opsonophagocytosis by preventing complement deposition and Fc
receptor binding
D. Secretion of superantigens that cause T-cell anergy
CORRECT ANSWER: C. Impairment of opsonophagocytosis by preventing
complement deposition and Fc receptor binding
Rationale: The pneumococcal capsule is a thick, hydrophilic polysaccharide layer that
masks underlying cell wall components. It inhibits the alternative complement pathway
and prevents the opsonization of bacteria with C3b and antibodies, thus hindering
recognition and phagocytosis by alveolar macrophages and neutrophils.
Question 5: Which of the following pharmacokinetic parameters is most useful
for determining the dosing interval of a drug that follows first-order
elimination kinetics?
A. Volume of distribution (Vd)
B. Bioavailability (F)
C. Half-life (t½)
D. Area under the curve (AUC)

,CORRECT ANSWER: C. Half-life (t½)
Rationale: The half-life of a drug is the time required for its plasma concentration to
decrease by 50%. In first-order kinetics, a constant fraction of the drug is eliminated per
unit of time. The half-life directly dictates the time required to reach steady-state and the
frequency at which doses should be administered to maintain therapeutic
concentrations without excessive accumulation.
Question 6: A 28-year-old woman presents with a malodorous, greenish, frothy
vaginal discharge. Microscopic examination of the discharge reveals motile,
flagellated trophozoites. The drug of choice for this infection acts by inhibiting
which of the following microbial processes?
A. Cell wall synthesis
B. Folic acid synthesis
C. DNA replication and repair via electron transport inhibition
D. Protein synthesis at the 70S ribosome
CORRECT ANSWER: C. DNA replication and repair via electron transport
inhibition
Rationale: The presentation is classic for trichomoniasis, caused by Trichomonas
vaginalis. The drug of choice is metronidazole. It is a prodrug that is reduced by
microbial ferredoxin-like proteins, leading to the formation of reactive cytotoxic radicals
that damage DNA and inhibit nucleic acid synthesis in the anaerobic organism.
Question 7: In a patient with a severe penicillin allergy, which of the following
antibiotics is considered safe for the treatment of a confirmed Group A
Streptococcus (Streptococcus pyogenes) pharyngitis?
A. Amoxicillin
B. A cephalosporin (e.g., cephalexin)
C. Clindamycin
D. Aztreonam
CORRECT ANSWER: C. Clindamycin
Rationale: For patients with a severe (Type I hypersensitivity) allergy to penicillin,
beta-lactams like cephalosporins and carbapenems carry a risk of cross-reactivity and
are generally avoided. Clindamycin, a lincosamide, inhibits bacterial protein synthesis
and is an effective alternative for treating streptococcal infections when penicillin is
contraindicated.
Question 8: The mechanism of action of vancomycin involves:
A. Inhibition of penicillin-binding proteins (PBPs)
B. Disruption of the bacterial cell membrane via a detergent-like effect
C. Binding to the D-alanyl-D-alanine terminus of cell wall precursors, preventing
transpeptidation
D. Interference with DNA gyrase activity

, CORRECT ANSWER: C. Binding to the D-alanyl-D-alanine terminus of cell wall
precursors, preventing transpeptidation
Rationale: Vancomycin is a glycopeptide antibiotic. It forms a stable complex with the
D-Ala-D-Ala dipeptide at the terminal end of the peptidoglycan precursor, lipid II. This
sterically hinders the action of transpeptidase and transglycosylase enzymes, effectively
blocking cell wall synthesis at a site distinct from beta-lactam antibiotics.
Question 9: A gram-negative rod is isolated from a patient's blood culture. It is
oxidase-negative, lactose-fermenting, and produces a greenish metallic sheen
on eosin-methylene blue (EMB) agar. Which virulence factor is most directly
associated with the potential for this organism to cause hemolytic uremic
syndrome (HUS)?
A. Lipopolysaccharide (LPS) endotoxin
B. Shiga toxin
C. Pili for adherence to intestinal epithelium
D. Capsular polysaccharide (K antigen)
CORRECT ANSWER: B. Shiga toxin
Rationale: The organism described is Escherichia coli O157:H7 (an
enterohemorrhagic E. coli). The production of Shiga toxin (Stx) is the primary virulence
factor linked to HUS. Stx damages vascular endothelial cells in the renal glomeruli,
leading to microangiopathic hemolytic anemia, thrombocytopenia, and acute renal
failure.
Question 10: A 72-year-old patient is prescribed digoxin for heart failure.
Which of the following electrolyte imbalances would most significantly
increase the risk of digoxin toxicity?
A. Hyperkalemia
B. Hypomagnesemia
C. Hypokalemia
D. Hypercalcemia
CORRECT ANSWER: C. Hypokalemia
Rationale: Digoxin inhibits the Na+/K+-ATPase pump. Low extracellular potassium
(hypokalemia) competes with digoxin for binding sites on the pump. This increases the
affinity of the pump for digoxin, thereby potentiating its effect and significantly
increasing the risk of cardiac arrhythmias and toxicity.
Question 11: A 32-year-old immunocompetent patient presents with a painful,
vesicular rash on an erythematous base localized to the right T5 dermatome.
The etiologic agent of this condition is a virus that establishes latency in
which of the following anatomical sites?
A. Dorsal root ganglia
B. Epithelial cells of the oropharynx

Document information

Uploaded on
September 1, 2026
Number of pages
67
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$18.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
BrightVarsity
3.4
(47)
Sold
1054
Followers
15
Items
3569
Last sold
4 days ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions